These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23209772)

  • 1. MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells.
    Campregher C; Schmid G; Ferk F; Knasmüller S; Khare V; Kortüm B; Dammann K; Lang M; Scharl T; Spittler A; Roig AI; Shay JW; Gerner C; Gasche C
    PLoS One; 2012; 7(11):e50541. PubMed ID: 23209772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
    Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
    Raeker MÖ; Pierre-Charles J; Carethers JM
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells.
    Tseng-Rogenski SS; Chung H; Wilk MB; Zhang S; Iwaizumi M; Carethers JM
    PLoS One; 2012; 7(11):e50616. PubMed ID: 23226332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
    Laycock A; Kang A; Ang S; Texler M; Bentel J
    Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.
    Lee SY; Chung H; Devaraj B; Iwaizumi M; Han HS; Hwang DY; Seong MK; Jung BH; Carethers JM
    Gastroenterology; 2010 Nov; 139(5):1519-25. PubMed ID: 20708618
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Villy MC; Masliah-Planchon J; Schnitzler A; Delhomelle H; Buecher B; Filser M; Merchadou K; Golmard L; Melaabi S; Vacher S; Blanluet M; Suybeng V; Corsini C; Dhooge M; Hamzaoui N; Farelly S; Ait Omar A; Benamouzig R; Caumette V; Bahuau M; Cucherousset J; Allory Y; Stoppa-Lyonnet D; Bieche I; Colas C
    J Med Genet; 2023 Nov; 60(12):1198-1205. PubMed ID: 37402566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.
    Plaschke J; Preußler M; Ziegler A; Schackert HK
    Int J Colorectal Dis; 2012 Jul; 27(7):911-9. PubMed ID: 22249440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer.
    Rashid M; Rashid R; Gadewal N; Carethers JM; Koi M; Brim H; Ashktorab H
    Neoplasia; 2024 Mar; 49():100970. PubMed ID: 38281411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
    Mori T; Hamaya Y; Uotani T; Yamade M; Iwaizumi M; Furuta T; Miyajima H; Osawa S; Sugimoto K
    PLoS One; 2018; 13(12):e0208557. PubMed ID: 30532127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.
    Plaschke J; Krüger S; Jeske B; Theissig F; Kreuz FR; Pistorius S; Saeger HD; Iaccarino I; Marra G; Schackert HK
    Cancer Res; 2004 Feb; 64(3):864-70. PubMed ID: 14871813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for discovering EMAST sequences in animal models of cancer.
    Bhaskaran N; Luu J; Kelley ST; Khan MW; Mamindla P; McGuire KL
    Sci Rep; 2018 Sep; 8(1):13764. PubMed ID: 30214002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.
    Tseng-Rogenski SS; Hamaya Y; Choi DY; Carethers JM
    Gastroenterology; 2015 Mar; 148(3):579-89. PubMed ID: 25461668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
    Park JM; Huang S; Tougeron D; Sinicrope FA
    PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.
    Carethers JM; Koi M; Tseng-Rogenski SS
    Genes (Basel); 2015 Mar; 6(2):185-205. PubMed ID: 25836926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.